Taken together, the above results indicate that the genetic and expression differences of m6A regulators are highly heterogeneous in CRC, suggesting that differences in the expression of m6A regulators might have a key role in the onset and progression of CRC. Here, METTL3 is linked to colorectal carcinoma.